Boosted by the COVID vaccine, Moderna’s valuation has now leapfrogged that of well-established Big Pharma giants like Bristol Myers Squibb and Sanofi. Can it last? Read More
Related Articles
China’s online propaganda isn’t very good
Influence campaigns appear to have diminishing returns. Read More
Digital patient vaccination records could be the foundation for a ‘vaccine passport’
Patient health information platform Healthvana has partnered with Los Angeles County to provide COVID-19 vaccination tracking to recipients. Primarily, the system will send patients followup reminders to return for the required second dose of the Pfizer-BioNTech or Moderna vaccines. But Healthvana also says its records create a verifiable proof of vaccination. That proof, sometimes discussed […]
COVID could Reevaluate the Way we go to the Films
Such as the shuttering of museums, concert halls, along with theatrical spaces throughout the nation throughout the ordeal, Cineworld’s decision last week to shut 536 Regal Cinemas at the U.S.–along with also furlough 40,000 workers –will be at once both profoundly debilitating and clear. The news just got worse this week, even since the greatest […]